Join
Live feed
·
INSIDERFilingvia Quantisnow
Organon & Co. logo

Interim CEO Morrissey Joseph T. Jr. was granted 35,341 shares and covered exercise/tax liability with 10,270 shares, increasing direct ownership by 38% to 98,571 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
OGN· Organon & Co.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track OGN (Organon & Co.) and more on Quantisnow.